NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I think it’s possible U. Penn’s presentation upcoming sometime in June on another “dimension” of efficacy in the DCVax-l trial would also not disrupt any journal embargo.

Look, usually journals follow presentations. Everybody knows that. Usually the journal does not want proprietary things given away ahead of time (example: detailed charts and graphs), but again, usually that stuff is revealed ahead of time anyway, such as in the market labeling records.